Federal Supply Schedule 36F79724D0074
Award Date
3/1/24
Last Date to Order
2/28/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
PTC Therapeutics US, Inc.
Ultimate Awardee
PTC Therapeutics, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to PTC Therapeutics, Inc. as the prime contractor. The BPA, valued at a ceiling of $12,500.00, is for the procurement of EMFLAZA, a medication. The BPA was awarded on March 9, 2024, with a period of performance ending on March 14, 2026. The contract was a single award, with no set-aside used. As a BPA, this contract provides a streamlined mechanism for the agency to order and...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to PTC Therapeutics, Inc., a for-profit organization, for pharmaceuticals and drugs under GSA Schedule 65 IB. The contract has a potential value of $3 million with a period of performance through February 2024. A Blanket Purchase Agreement against this contract was also awarded to PTC Therapeutics for $500,000, running through November...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Adaptimmune LLC, a foreign-owned for-profit manufacturer. The contract has a ceiling value of $225,000.00 and a period of performance ending on March 14, 2030. The contract is for the procurement of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Federal Supply Schedule (FSS) contract vehicle. Additionally, a single-award Blanket Purchase...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to EDW Pharma, Inc. for the procurement of pharmaceutical and hematology-related products. The multiple-award, indefinite delivery vehicle (IDV) has a ceiling value of $420,000.00 and a period of performance through August 14, 2026. The contract also includes a single-award Blanket Purchase Agreement (BPA) under the same Federal Supply Schedule, which was awarded to ITF Pharma Inc. for the specific...
The provided information describes a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Catalyst Pharmaceuticals, Inc. The BPA, valued at $5,500,000, is placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of July 25, 2026. The primary purpose of this BPA is to enable the procurement of the pharmaceutical product Firdapse (amifampridine), an FDA-approved...
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Acorda Therapeutics, Inc. for the procurement of Inbrija and Ampyra. The contract has a potential value of $7.5 million and a period of performance through January 2024. The contract was awarded off the Pharmaceuticals and Drugs Federal Supply Schedule and provides a single award vehicle for ordering Inbrija, a treatment for off episodes related to Parkinson's disease, and Ampyra, a...
The provided information describes a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The single-award BPA (Contract #36E79724A0005) has a ceiling value of $5,500,000 and is effective from January 18, 2024 to September 19, 2024. It was awarded without the use of a set-aside and enables the...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The BPA has a ceiling value of $118,500,000 and a period of performance from August 2024 to August 2026, with an option year extending it to August 2027. The BPA is for the procurement of specialized pharmaceutical products, primarily focused on medications for the treatment of rare diseases and pulmonary...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Zyla Life Sciences US, LLC (doing business as Egalet Corp Delaware). The contract has a period of performance from July 15, 2025 to July 14, 2030 and a ceiling value of $13,243,650.00. The contract is for the procurement of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under FSC Code 65 I B. As an FSS contract, it allows for the...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Sarepta Therapeutics, Inc. The contract is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB, with a ceiling value of $225,000.00 and a period of performance through May 31, 2026. The contract was awarded on a multiple-award basis, with no set-asides used. As a Federal Supply Schedule contract, this vehicle allows...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
36F79724D0074-36E79724A0007 | PTC Therapeutics, Inc. | $12.5k | 3/9/24 | 3/14/26 | 2/5/25 |